Cervical Cancer

Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery

Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery

By

A comparison study of 2 approaches to radical hysterectomy found that disease-free and overall survival are worse with minimally invasive procedure than with abdominal open procedure, contradicting previous study findings.

Open Hysterectomy Survival Rates Edge Minimally Invasive Procedures for Cervical Cancer

Open Hysterectomy Survival Rates Edge Minimally Invasive Procedures for Cervical Cancer

By

A population-based study compared open abdominal radical hysterectomy with minimally invasive robot-assisted radical hysterectomy, and found a slight edge in survival among those who underwent the open procedure.

FDA Approves HPV Vaccine for People Through Age 45

FDA Approves HPV Vaccine for People Through Age 45

Updated vaccine designed to prevent cancers and disease caused by nine HPV types

CDC: HPV Vaccination Rates on the Rise Among Adolescents

CDC: HPV Vaccination Rates on the Rise Among Adolescents

Proportion of teens up to date with HPV vaccines also increasing, researchers found.

Failure Rates for HPV Vaccine Higher in HIV-Positive Women, Girls

Failure Rates for HPV Vaccine Higher in HIV-Positive Women, Girls

By

Canadian investigators conducted a national observational study in which women and girls living with HIV underwent HPV vaccination.

Primary HPV testing may detect cervical neoplasms earlier and more accurately than cytology

1. In this Canadian, randomized controlled trial, the use of primary HPV testing compared with cytology resulted in a significantly lower likelihood of CIN3+ at 48 months. 2. There was also significantly fewer CIN2+ cases in women screened with HPV testing compared with women who were screened with cytology alone at baseline. Evidence Rating: 1 []

USPSTF Updates Its Recommendations for Cervical Cancer Screening

USPSTF Updates Its Recommendations for Cervical Cancer Screening

By

The US Preventive Services Task Force conducted a review of trials and cohort studies to support an update of its cervical cancer screening recommendations for women ages 21 to 65 and older.

CDC Reports Screening Drop in Breast, Cervical, and Prostate Cancers

CDC Reports Screening Drop in Breast, Cervical, and Prostate Cancers

By

CDC investigators found that from 2000 to 2015, screening for breast, cervical, and prostate cancers decreased significantly.

High-certainty Evidence That HPV Vaccines Protect Against Cervical Precancer

High-certainty Evidence That HPV Vaccines Protect Against Cervical Precancer

High-certainty evidence for cervical cancer protection in adolescent girls and young women aged 15 to 26 years.

Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer

Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer

By

A study presented at the 2018 ONS Annual Congress explored whether aromatherapy and reflexology can ease anxiety and pain for patients undergoing brachytherapy for cervical cancer.

Cervical Cancer Outcomes Comparable With Adjuvant Chemotherapy, Chemoradiotherapy

Cervical Cancer Outcomes Comparable With Adjuvant Chemotherapy, Chemoradiotherapy

By

Researchers compared the efficacy of chemotherapy alone vs concurrent chemoradiotherapy (CCRT) for use after radical hysterectomy among patients with early-stage cervical cancer with risk factors,

Cancer Screening Follow-up: Enabling Timely Diagnosis, Treatment

Cancer Screening Follow-up: Enabling Timely Diagnosis, Treatment

By

A review of the literature on follow-up after positive screening results led researchers to a consensus opinion on timing of diagnostic tests for 4 cancers: breast, cervical, colorectal, and lung.

Comparison of Survival Outcomes Between Radical Hysterectomy and Definitive Radiochemotherapy in Stage IB1 and IIA1 Cervical Cancer

Comparison of Survival Outcomes Between Radical Hysterectomy and Definitive Radiochemotherapy in Stage IB1 and IIA1 Cervical Cancer

[Cancer Management and Research] A comparison study evaluated whether radical hysterectomy or radiochemotherapy provides superior survival outcomes for patients with stage IB1 or IIA1 cervical cancer.

Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer

Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer

By

In an effort to find alternatives to cisplatin as a radiation sensitizer, due to its dose-dependent toxicity and resistance, researchers are exploring food-based options such as blueberry extract.

HPV and Cancer (Fact Sheet)

HPV and Cancer (Fact Sheet)

This fact sheet examines possible links between human papillomaviruses (HPVs) and cancer.

Incidence of Invasive Cervical Cancer May Not Be Affected by HIV Status

Incidence of Invasive Cervical Cancer May Not Be Affected by HIV Status

By

HIV infection may not have a contributory effect on the incidence of invasive cervical cancer (ICC) in women as they age.

Vaccine for Cervical Cancer Could Extend Survival in Relapsed Disease

Vaccine for Cervical Cancer Could Extend Survival in Relapsed Disease

Axalimogene filolisbac, an intravenous vaccine currently in clinical trials, could prevent often-fatal cervical cancer relapse.

Cervical Cancer Survivors Prone to Long-Term Fatigue, Insomnia

Cervical Cancer Survivors Prone to Long-Term Fatigue, Insomnia

Fatigue and insomnia can persist for many cervical cancer survivors years after their treatment, and have a serious impact on quality of life.

ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention

ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention

By

ASCO offers global recommendations for HPV vaccination tailored to structural resource levels of regions.

Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates

Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates

By

Self-persuasion is more effective than external persuasion for motivating low-income parents to vaccinate their children against HPV.

High Rates of Persistent Opioid Use 6 Months After RT for Cervical Cancer

High Rates of Persistent Opioid Use 6 Months After RT for Cervical Cancer

By

Nearly 3 in 10 cervical cancer survivors were still using opioids at 6 months after completing radiotherapy.

Nonadherence to Guidelines, Low-Volume Centers Linked to Lower Cervical Cancer Survival

Nonadherence to Guidelines, Low-Volume Centers Linked to Lower Cervical Cancer Survival

By

Nonadherence to NCCN guideline treatment recommendations was strongly associated with decreased survival from early-stage cervical cancer.

HPV Vaccination Discussions Need to Focus on Education, Awareness

HPV Vaccination Discussions Need to Focus on Education, Awareness

By

The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.

Multidisciplinary Team Approach Reduces Cervical Cancer Treatment Delays in Low-Resource Areas

Multidisciplinary Team Approach Reduces Cervical Cancer Treatment Delays in Low-Resource Areas

By

Multidisciplinary team approach reduces cervical cancer treatment delays in Botswana by 50%.

Alarming Racial Disparities in Cervical Cancer Mortality Rates

Alarming Racial Disparities in Cervical Cancer Mortality Rates

By

A new study that only included women with a cervix has found the risk of dying from cervical cancer is higher than previously thought.

Standard of Care Underused for Advanced Cervical Cancer

Standard of Care Underused for Advanced Cervical Cancer

Despite improved overall survival with standard of care, less than half of patients with locally advanced cervical cancer receive SOC treatment.

New Recommendations for Secondary Prevention of Cervical Cancer

New Recommendations for Secondary Prevention of Cervical Cancer

HPV DNA testing recommended in all resource settings; HIV should undergo screening more often

Low Incidence of Cervical Cancer for HPV-Negative Women

Low Incidence of Cervical Cancer for HPV-Negative Women

Human papillomavirus (HPV)-negative women have low long-term incidence of cervical cancer and CIN3+, which supports an extension of the cervical screening interval beyond five years for some, according to a study.

Additional Evidence HPV Vaccine Protects Against Cervical Cancer

Additional Evidence HPV Vaccine Protects Against Cervical Cancer

The vaccine against human papillomavirus (HPV) infection appears even more effective than previously believed and protection appears to occur even when only one or two of the recommended doses are given.

HIV Infection Worsens Survival of Patients With Cervical Cancer

HIV Infection Worsens Survival of Patients With Cervical Cancer

By

HIV is associated with reduced cancer-specific survival among women with invasive cervical cancer.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs